Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1961 7
1963 1
1964 2
1965 1
1966 1
1967 2
1968 1
1969 3
1970 2
1971 3
1972 1
1973 5
1974 7
1975 5
1976 9
1977 4
1978 5
1979 17
1980 16
1981 12
1982 9
1983 5
1984 24
1985 23
1986 20
1987 24
1988 33
1989 27
1990 59
1991 58
1992 31
1993 37
1994 57
1995 38
1996 33
1997 33
1998 56
1999 57
2000 71
2001 49
2002 50
2003 81
2004 62
2005 80
2006 85
2007 88
2008 80
2009 97
2010 116
2011 93
2012 92
2013 106
2014 96
2015 71
2016 100
2017 84
2018 77
2019 86
2020 109
2021 133
2022 136
2023 143
2024 58

Text availability

Article attribute

Article type

Publication date

Search Results

2,727 results

Results by year

Filters applied: . Clear all
Page 1
Takayasu phlebitis.
Katayama Y, Matsumoto Y, Yamamura Y, Asano Y, Hayashi K, Ohashi K, Morishita M, Watanabe H, Narazaki M, Sada KE, Wada J. Katayama Y, et al. Rheumatology (Oxford). 2020 Dec 1;59(12):e131-e133. doi: 10.1093/rheumatology/keaa333. Rheumatology (Oxford). 2020. PMID: 32617559 No abstract available.
Biomaterial-Assisted Regenerative Medicine.
Nii T, Katayama Y. Nii T, et al. Among authors: katayama y. Int J Mol Sci. 2021 Aug 12;22(16):8657. doi: 10.3390/ijms22168657. Int J Mol Sci. 2021. PMID: 34445363 Free PMC article. Review.
Mirogabalin for Central Neuropathic Pain After Spinal Cord Injury: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study in Asia.
Ushida T, Katayama Y, Hiasa Y, Nishihara M, Tajima F, Katoh S, Tanaka H, Maeda T, Furusawa K, Richardson M, Kakehi Y, Kikumori K, Kuroha M. Ushida T, et al. Among authors: katayama y. Neurology. 2023 Mar 14;100(11):e1193-e1206. doi: 10.1212/WNL.0000000000201709. Epub 2022 Dec 14. Neurology. 2023. PMID: 36517235 Free PMC article. Clinical Trial.
TTF-1 Expression and Clinical Outcomes of Combined Chemoimmunotherapy in Patients With Advanced Lung Adenocarcinoma: A Prospective Observational Study.
Katayama Y, Yamada T, Morimoto K, Fujii H, Morita S, Tanimura K, Takeda T, Okada A, Shiotsu S, Chihara Y, Hiranuma O, Yamada T, Ota T, Harada T, Hasegawa I, Yoshimura A, Iwasaku M, Tokuda S, Kim YH, Takayama K. Katayama Y, et al. JTO Clin Res Rep. 2023 Mar 7;4(4):100494. doi: 10.1016/j.jtocrr.2023.100494. eCollection 2023 Apr. JTO Clin Res Rep. 2023. PMID: 37020925 Free PMC article.
Machine Learning Approaches to TCR Repertoire Analysis.
Katayama Y, Yokota R, Akiyama T, Kobayashi TJ. Katayama Y, et al. Front Immunol. 2022 Jul 15;13:858057. doi: 10.3389/fimmu.2022.858057. eCollection 2022. Front Immunol. 2022. PMID: 35911778 Free PMC article. Review.
Tumor Neovascularization and Developments in Therapeutics.
Katayama Y, Uchino J, Chihara Y, Tamiya N, Kaneko Y, Yamada T, Takayama K. Katayama Y, et al. Cancers (Basel). 2019 Mar 6;11(3):316. doi: 10.3390/cancers11030316. Cancers (Basel). 2019. PMID: 30845711 Free PMC article. Review.
Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO).
Bernstein P, Dysli C, Fischer J, Hammer M, Katayama Y, Sauer L, Zinkernagel MS. Bernstein P, et al. Among authors: katayama y. 2019 Aug 14. In: Bille JF, editor. High Resolution Imaging in Microscopy and Ophthalmology: New Frontiers in Biomedical Optics [Internet]. Cham (CH): Springer; 2019. Chapter 10. 2019 Aug 14. In: Bille JF, editor. High Resolution Imaging in Microscopy and Ophthalmology: New Frontiers in Biomedical Optics [Internet]. Cham (CH): Springer; 2019. Chapter 10. PMID: 32091850 Free Books & Documents. Review.
Concomitant Proton Pump Inhibitor Use With Pembrolizumab Monotherapy vs Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With Non-Small Cell Lung Cancer.
Kawachi H, Yamada T, Tamiya M, Negi Y, Goto Y, Nakao A, Shiotsu S, Tanimura K, Takeda T, Okada A, Harada T, Date K, Chihara Y, Hasegawa I, Tamiya N, Ishida M, Katayama Y, Morimoto K, Iwasaku M, Tokuda S, Kijima T, Takayama K. Kawachi H, et al. Among authors: katayama y. JAMA Netw Open. 2023 Jul 3;6(7):e2322915. doi: 10.1001/jamanetworkopen.2023.22915. JAMA Netw Open. 2023. PMID: 37432682 Free PMC article.
MDS cells impair osteolineage differentiation of MSCs via extracellular vesicles to suppress normal hematopoiesis.
Hayashi Y, Kawabata KC, Tanaka Y, Uehara Y, Mabuchi Y, Murakami K, Nishiyama A, Kiryu S, Yoshioka Y, Ota Y, Sugiyama T, Mikami K, Tamura M, Fukushima T, Asada S, Takeda R, Kunisaki Y, Fukuyama T, Yokoyama K, Uchida T, Hagihara M, Ohno N, Usuki K, Tojo A, Katayama Y, Goyama S, Arai F, Tamura T, Nagasawa T, Ochiya T, Inoue D, Kitamura T. Hayashi Y, et al. Among authors: katayama y. Cell Rep. 2022 May 10;39(6):110805. doi: 10.1016/j.celrep.2022.110805. Cell Rep. 2022. PMID: 35545056 Free article.
Anti-tumor effects of perampanel in malignant glioma cells.
Tatsuoka J, Sano E, Hanashima Y, Yagi C, Yamamuro S, Sumi K, Hara H, Takada K, Kanemaru K, Komine-Aizawa S, Katayama Y, Yoshino A. Tatsuoka J, et al. Among authors: katayama y. Oncol Lett. 2022 Oct 7;24(6):421. doi: 10.3892/ol.2022.13541. eCollection 2022 Dec. Oncol Lett. 2022. PMID: 36284648 Free PMC article.
2,727 results